Internal tandem duplications of the fms-like tyrosine kinase 3 (FLT3) gene (FLT3-ITDmut) characterize ~25% of AML and represent an independent predictor of poor prognosis, being associated with an increased risk of relapse3,4. The gene discussed is FLT3; the disease is acute myeloid leukemia.